Description
(2R,3R,4S,5S,6R)-2-[[(3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol;(2R,3R,4S,5S,6R)-2-[[(3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylhept-6-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol (CAS: 57126-62-2) is a high-purity steroidal glycoside mixture commonly referred to as Charantin. This compound consists of a 1:1 mixture of 25,26-Dehydro-β-Sitosterol β-D-Glucoside and β-Sitosterol β-D-Glucoside, with a molecular formula of C70H118O12. It is widely utilized in research and pharmaceutical applications due to its bioactive properties. Our product is rigorously tested for purity and consistency, ensuring optimal performance in scientific studies. Ideal for researchers investigating plant-derived sterols and their physiological effects.
Properties
- CAS Number: 57126-62-2
- Complexity: 1880
- IUPAC Name: (2R,3R,4S,5S,6R)-2-[[(3S,8S,9S,10R,13R,14S,17R)-17-[(1R,4R)-4-ethyl-1,5-dimethyl-hex-5-enyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol;(2R,3R,4S,5S,6R)-2-[[(3S,8S,9S,10R,13R,14S,17R)-17-[(1R,4R)-4-ethyl-1,5-dimethyl-hexyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
- InChI: InChI=1S/C35H60O6.C35H58O6/c2*1-7-22(20(2)3)9-8-21(4)26-12-13-27-25-11-10-23-18-24(14-16-34(23,5)28(25)15-17-35(26,27)6)40-33-32(39)31(38)30(37)29(19-36)41-33/h10,20-22,24-33,36-39H,7-9,11-19H2,1-6H3;10,21-22,24-33,36-39H,2,7-9,11-19H2,1,3-6H3/t2*21-,22-,24+,25+,26-,27+,28+,29-,30-,31+,32-,33-,34+,35-/m11/s1
- InChI Key: LDASQDTWGMPHCX-WCFKDQIASA-N
- Exact Mass: 1150.86232920
- Molecular Formula: C70H118O12
- Molecular Weight: 1151.7
- SMILES: CC[C@H](CC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C)C)C(C)C.CC[C@H](CC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C)C)C(=C)C
- Topological: 199
- Monoisotopic Mass: 1150.86232920
- Synonyms: 57126-62-2, Charantin (1:1 mixture of 25,26-Dehydro ?-Sitosterol ?-D-Glucoside and ?-Sitosterol ?-D-Glucoside), mixture of Stigmasta-5,25-dien-3ss-yl ss-D-glucopyranoside and ss-Sitosteryl glucoside
Charantin is primarily studied for its potential hypoglycemic and anti-diabetic properties. Researchers use it to investigate its effects on glucose metabolism and insulin sensitivity. It is also explored in nutraceutical and phytochemical research for its bioactive potential. Suitable for in vitro and in vivo studies focusing on metabolic disorders.
If you are interested or have any questions, please contact us at support@atomfair.com
Disclaimer: Sold exclusively for laboratory research. Prohibited for commercial use, diagnostics, or human/animal applications. Buyers assume all compliance liability.


Reviews
There are no reviews yet.